Evir Therapeutics

Evir Therapeutics is focused on developing innovative therapies for age-related macular degeneration (AMD) and other ocular diseases, leveraging expertise in ophthalmology and gene therapy

Biotech & Life Sciences

Sector

Seed

Stage

Biopharmaceutical development

Model

01Company Overview

Evir Therapeutics is focused on developing innovative therapies for age-related macular degeneration (AMD) and other ocular diseases, leveraging expertise in ophthalmology and gene therapy.

02Backed By1 investor

+C+ND Capital Fund (f.k.a. NanoDimension)→

03Similar Companies